Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
89bio | ETNB | Apr 24, 2024 | 8.58 | -3.81 |
Aligos Therapeutics | ALGS | Apr 24, 2024 | 0.83 | +0.66 |
ALX Oncology | ALXO | Apr 24, 2024 | 16.22 | +4.65 |
Annexon | ANNX | Apr 24, 2024 | 4.45 | +0.23 |
BioVie | BIVI | Apr 24, 2024 | 0.51 | +2.77 |
Cerevel Therapeutics | CERE | Apr 24, 2024 | 41.90 | -0.21 |
Chromadex | CDXC | Apr 24, 2024 | 3.40 | 0.00 |
Dyne Therapeutics | DYN | Apr 24, 2024 | 24.98 | -1.81 |
Exicure | XCUR | Apr 24, 2024 | 0.52 | -4.68 |
Fusion Pharmaceuticals | FUSN | Apr 24, 2024 | 21.40 | -0.09 |
Galapagos ADR | GLPG | Apr 24, 2024 | 28.77 | -2.31 |
Generation Bio | GBIO | Apr 24, 2024 | 2.99 | -8.28 |
Greenwich LifeSciences | GLSI | Apr 24, 2024 | 12.62 | -3.96 |
Inhibrx | INBX | Apr 24, 2024 | 34.38 | +0.73 |
Inozyme Pharma | INZY | Apr 24, 2024 | 4.40 | 0.00 |
Inventiva ADR | IVA | Apr 24, 2024 | 3.24 | -1.52 |
iTeos Therapeutics | ITOS | Apr 24, 2024 | 10.57 | -3.82 |
Keros Therapeutics | KROS | Apr 24, 2024 | 56.24 | +1.90 |
Kintara Therapeutics | KTRA | Apr 24, 2024 | 0.14 | +3.47 |
Kronos Bio | KRON | Apr 24, 2024 | 0.96 | +1.05 |
Kymera Therapeutics | KYMR | Apr 24, 2024 | 35.21 | -1.40 |
Legend Biotech ADR | LEGN | Apr 24, 2024 | 45.17 | -4.81 |
Lyra Therapeutics | LYRA | Apr 24, 2024 | 5.23 | +0.38 |
Nautilus Biotechnology | NAUT | Apr 24, 2024 | 2.40 | -3.61 |
Nurix Therapeutics | NRIX | Apr 24, 2024 | 13.75 | -2.69 |
Nuvation Bio A | NUVB | Apr 24, 2024 | 2.66 | -0.75 |
Oric Pharmaceuticals | ORIC | Apr 24, 2024 | 8.08 | -7.87 |
PMV Pharmaceuticals | PMVP | Apr 24, 2024 | 1.69 | -6.37 |
Poseida Therapeutics | PSTX | Apr 24, 2024 | 2.07 | -4.17 |
Prelude Therapeutics | PRLD | Apr 24, 2024 | 3.87 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.